No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
969 |
4. Check minimum number of eventsNone |
969 |
5. Include endpointsNone |
969 |
6. Filter based on genotype QC (FinnGen only) |
969 |
Control definitions (FinnGen only)
- Control exclude
- H8_MIDDLEMASTOID
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- H70
- Name in latin
- Mastoiditis chronica
Similar endpoints
↥List of similar endpoints to
Chronic mastoiditis
based on the number of shared cases.
Similar with more cases:
- Diseases of middle ear and mastoid
- Diseases of the ear and mastoid process
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 8589 | 3987 | 4494 |
| Only index persons | 7007 | 3397 | 3610 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.12 | 0.11 | 0.13 |
| Only index persons | 0.13 | 0.12 | 0.14 |
| Median age at first event (years) | |||
| Whole population | 40.57 | 43.01 | 38.15 |
| Only index persons | 37.44 | 40.07 | 34.97 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 969 | 433 | 536 |
| Unadjusted period prevalence (%) | 0.20 | 0.15 | 0.24 |
| Median age at first event (years) | 41.15 | 40.26 | 41.88 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 886
- Matched controls
- 8858
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
38210
ICD-8 Finland
Chronic otitis media with mastoiditis
+∞
323.0
472
*
H70.1
ICD-10 Finland
Chronic mastoiditis
6946.7
323.0
408
*
H71
ICD-10 Finland
Cholesteatoma of middle ear
2735.1
240.9
222
*
H65.3
ICD-10 Finland
Chronic mucoid otitis media
317.8
136.4
135
5
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
369.5
128.0
126
*
38110
ICD-8 Finland
Otitis media without mention of mastoiditis, Chronic
+∞
120.6
113
*
H90.6
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
42.8
110.8
138
38
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
370.5
99.1
98
*
DC1AD
NOMESCO Finland
Temporalbone CT
71.0
98.5
112
18
UDC00
NOMESCO Finland
Ear microscopy
9.7
96.7
213
281
H66.0
ICD-10 Finland
Acute suppurative otitis media
16.2
89.2
149
109
H66.4
ICD-10 Finland
Suppurative otitis media, unspecified
144.3
75.3
79
6
Z01.1
ICD-10 Finland
Examination of ears and hearing
5.2
73.3
264
665
H66.3
ICD-10 Finland
Other chronic suppurative otitis media
252.9
69.3
70
*
H65.2
ICD-10 Finland
Chronic serous otitis media
252.9
69.3
70
*
DFF00
NOMESCO Finland
Pure tone audiometry
6.4
68.7
200
386
38700
ICD-8 Finland
Other disease of ear and mastoid process, Cholesteatoma of ear
+∞
68.6
65
*
H66.9
ICD-10 Finland
Otitis media, unspecified
12.0
67.2
128
123
DCD00
NOMESCO Finland
Myringoplasty
663.5
63.7
62
*
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
4.1
63.6
303
991
DEB20
NOMESCO Finland
Attico-antro-mastoidectomy and tympanotomy
594.6
57.3
56
*
S02CA02
ATC
flumetasone and antiinfectives; otic
7.5
56.4
142
220
DEB10
NOMESCO Finland
Attico-antro-mastoidectomy
+∞
53.7
51
*
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
119.4
52.4
56
5
3853A
ICD-9 Finland
Other disorders of middle ear and mastoid, Cholesteatoma of middle ear and mastoid
+∞
49.4
47
*
DEB25
NOMESCO Finland
Attico-antro-mastoidectomy and tympanoplasty
+∞
49.4
47
*
3821A
ICD-9 Finland
Suppurative and unspecified otitis media, Chronic tubotympanic suppurative otitis media
+∞
48.4
46
*
S03CA01
ATC
dexamethasone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)
13.1
48.3
87
73
38100
ICD-8 Finland
Otitis media without mention of mastoiditis, Acute
+∞
46.2
44
*
H60.3
ICD-10 Finland
Other infective otitis externa
13.6
45.4
80
64
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
3.0
44.1
329
1447
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
5.2
43.6
147
327
Z97.4
ICD-10 Finland
Presence of external hearing-aid
6.2
42.4
121
220
DEB30
NOMESCO Finland
Radical mastoidectomy
+∞
40.9
39
*
H74.1
ICD-10 Finland
Adhesive middle ear disease
+∞
37.8
36
*
4141
FHL
Myringoplasty (also for reasons other than inflammation)
371.7
36.2
36
*
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
8.2
36.1
83
110
38402
ICD-8 Finland
Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) non definita
+∞
35.7
34
*
DBD20
NOMESCO Finland
Plastic repair of external auditory canal
81.6
35.1
39
5
H60.9
ICD-10 Finland
Otitis externa, unspecified
5.6
34.6
106
209
4151
FHL
Reoperation for chronic otitis media
339.1
33.1
33
*
H65.1
ICD-10 Finland
Other acute nonsuppurative otitis media
121.3
32.9
35
*
DCD10
NOMESCO Finland
Tympanoplasty
+∞
32.5
31
*
TDA90
NOMESCO Finland
Removal wax from ear
15.1
32.3
54
38
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.3
32.3
480
2969
H90.7
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
16.3
31.6
51
33
3812A
ICD-9 Finland
Nonsuppurative otitis media and Eustachian tube disorders, Chronic mucoid otitis media
+∞
30.4
29
*
H60.8
ICD-10 Finland
Other otitis externa
10.2
30.3
61
64
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
5.6
30.0
91
177
H90.1
ICD-10 Finland
Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
16.3
29.7
48
31
38199
ICD-8 Finland
Otitis media without mention of mastoiditis, Unspecified
+∞
29.3
28
*
H90.0
ICD-10 Finland
Conductive hearing loss, bilateral
22.0
28.9
42
20
H65.0
ICD-10 Finland
Acute serous otitis media
37.4
28.5
36
10
H65.4
ICD-10 Finland
Other chronic nonsuppurative otitis media
290.2
27.9
28
*
H72.2
ICD-10 Finland
Other marginal perforations of tympanic membrane
290.2
27.9
28
*
H66.1
ICD-10 Finland
Chronic tubotympanic suppurative otitis media
64.1
27.1
31
5
H70.0
ICD-10 Finland
Acute mastoiditis
279.1
26.9
27
*
50099
ICD-8 Finland
Hypertrophy of tonsils and adenoids
3.8
26.3
120
351
H95.0
ICD-10 Finland
Recurrent cholesteatoma of postmastoidectomy cavity
+∞
26.2
25
*
38401
ICD-8 Finland
Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) chronica adhaesiva
+∞
26.2
25
*
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
3.0
26.0
166
626
R5120
NOMESCO Finland
Preparation of an aid
7.1
26.0
65
98
S03CA04
ATC
hydrocortisone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)
7.2
25.0
62
92
4122
FHL
Tympanostomy (tympanic tube)
256.9
24.8
25
*
H95.1
ICD-10 Finland
Other disorders following mastoidectomy
256.9
24.8
25
*
H72.9
ICD-10 Finland
Perforation of tympanic membrane, unspecified
42.7
23.7
29
7
4144
FHL
Mastoidectomy or aticomastoidectomy
+∞
23.0
22
*
Z3229
NOMESCO Finland
Other healthcare associate professional
3.2
21.7
125
434
DFF15
NOMESCO Finland
Speech audiometry
4.5
21.1
77
183
DEA10
NOMESCO Finland
Attico-antrotomy
+∞
20.9
20
*
3842A
ICD-9 Finland
Other disorders of tympanic membrane, Perforation of tympanic membrane
+∞
20.9
20
*
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
5.4
20.5
63
124
4147
FHL
Radical surgery, cavity filling and middle ear and / or eardrum plastic
+∞
19.9
19
*
DEB00
NOMESCO Finland
Cortical mastoidectomy
+∞
18.8
18
*
H66
ICD-10 Finland
Suppurative and unspecified otitis media
8.7
18.6
40
48
J01DA06
ATC
[U] cefuroxime; systemic
2.5
17.9
154
684
J01FF01
ATC
clindamycin; systemic
2.0
16.2
249
1441
4145
FHL
Tympanomastoidectomy, includes possible tympanoplasty
+∞
15.7
15
*
R5140
NOMESCO Finland
Monitoring the use of the aid
2.6
14.7
116
489
H66.2
ICD-10 Finland
Chronic atticoantral suppurative otitis media
+∞
14.6
14
*
38299
ICD-8 Finland
Unspecified otitis media with mastoiditis
+∞
14.6
14
*
H74.2
ICD-10 Finland
Discontinuity and dislocation of ear ossicles
+∞
14.6
14
*
DGW00
NOMESCO Finland
Dilatation of eustachian tube
+∞
14.6
14
*
J01DA01
ATC
[U] cefalexin; systemic
1.8
14.5
551
4279
DAX08
NOMESCO Finland
Fitting of hearing aid
3.5
14.3
67
200
J01CA04
ATC
amoxicillin; systemic
1.8
14.2
666
5512
H61.2
ICD-10 Finland
Impacted cerumen
3.2
13.8
74
245
R01AD08
ATC
fluticasone; nasal
1.9
13.7
240
1444
H72.8
ICD-10 Finland
Other perforations of tympanic membrane
76.3
13.6
15
*
3831A
ICD-9 Finland
Mastoiditis and related conditions, Chronic mastoiditis
+∞
13.6
13
*
H73.1
ICD-10 Finland
Chronic myringitis
+∞
13.6
13
*
H60.4
ICD-10 Finland
Cholesteatoma of external ear
34.6
13.5
17
5
H65.9
ICD-10 Finland
Nonsuppurative otitis media, unspecified
142.1
13.5
14
*
H04
ICPC
Ear discharge
4.2
13.4
50
123
H92.0
ICD-10 Finland
Otalgia
3.8
12.9
54
147
J01MA02
ATC
ciprofloxacin; systemic
1.7
12.8
364
2556
H60
ICD-10 Finland
Otitis externa
3.8
12.6
53
145
4150
FHL
Tympanoplasty (including for reasons other than inflammation)
131.8
12.5
13
*
H72.1
ICD-10 Finland
Attic perforation of tympanic membrane
131.8
12.5
13
*
H90.4
ICD-10 Finland
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
3.7
12.1
52
145
DFF30
NOMESCO Finland
Loudness discomfort Level (LDL)
4.3
12.1
44
106
4143
FHL
Atticotomy or atticoanthromy through the ear canal
+∞
11.5
11
*
J01FA10
ATC
azithromycin; systemic
1.6
11.4
432
3257
H92.1
ICD-10 Finland
Otorrhoea
35.5
11.3
14
*
J01DC02
ATC
cefuroxime; systemic
3.2
11.1
57
184
H60.5
ICD-10 Finland
Acute otitis externa, noninfective
9.4
11.0
22
24
H95.8
ICD-10 Finland
Other postprocedural disorders of ear and mastoid process
+∞
10.4
10
*
DC1BD
NOMESCO Finland
Temporal bone extensive CT
+∞
10.4
10
*
4451
FHL
Guitar cutting
8.3
10.4
22
27
H02AB04
ATC
methylprednisolone; systemic
2.0
10.1
133
712
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
9.9
389
2923
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.7
9.8
66
255
H02AB06
ATC
prednisolone; systemic
1.6
9.7
399
3021
1450
FHL
Otomicroscopy
55.6
9.7
11
*
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.7
9.4
40
112
DCW99
NOMESCO Finland
Other operation on eardrum and middle ear
+∞
9.4
9
*
DDD05
NOMESCO Finland
Plastic repair of ossicular chain
+∞
9.4
9
*
38310
ICD-8 Finland
Mastoiditis without mention of otitis media, Chronic
+∞
9.4
9
*
46100
ICD-8 Finland
Acute sinusitis, Maxillaris
4.8
8.8
28
60
H91.9
ICD-10 Finland
Hearing loss, unspecified
3.2
8.8
45
147
H01
ICPC
Ear pain/earache
2.2
8.6
84
394
RK320
NOMESCO Finland
NA
7.0
8.6
20
29
H60.0
ICD-10 Finland
Abscess of external ear
16.5
8.6
13
8
J01DB01
ATC
cefalexin; oral
1.6
8.4
666
5810
4146
FHL
Radical cutting (bridge broken)
+∞
8.3
8
*
3820A
ICD-9 Finland
Suppurative and unspecified otitis media, Acute suppurative otitis media
+∞
8.3
8
*
H74.4
ICD-10 Finland
Polyp of middle ear
+∞
8.3
8
*
H90.8
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, unspecified
14.6
8.2
13
9
ZXA00
NOMESCO Finland
Right side
1.6
8.1
240
1658
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
8.0
231
1584
RK420
NOMESCO Finland
NA
45.4
7.7
9
*
R01BA52
ATC
pseudoephedrine, combinations; oral
1.6
7.7
228
1572
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.3
7.7
70
318
J33.8
ICD-10 Finland
Other polyp of sinus
4.0
7.6
29
75
J01DA08
ATC
[U] cefaclor; oral
2.2
7.5
76
364
R03DC03
ATC
montelukast; oral
1.8
7.4
119
687
50300
ICD-8 Finland
Chronic sinusitis, Maxillaris cum empyemate
8.5
7.3
15
18
H70.9
ICD-10 Finland
Mastoiditis, unspecified
+∞
7.3
7
*
38200
ICD-8 Finland
Acute / Acute otitis media with mastoiditis
+∞
7.3
7
*
DED00
NOMESCO Finland
Obliteration of cavity after partial excision of mastoid
+∞
7.3
7
*
DC1AA
NOMESCO Finland
Temporalbone X-ray examination
+∞
7.3
7
*
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.6
7.2
211
1446
S02CA03
ATC
hydrocortisone and antiinfectives; otic
30.3
7.2
9
*
H68.1
ICD-10 Finland
Obstruction of Eustachian tube
8.9
7.1
14
16
TDM10
NOMESCO Finland
Puncture of maxillary antrum
3.1
7.0
36
119
J01MA12
ATC
levofloxacin; systemic
1.7
6.9
169
1105
R01AD09
ATC
mometasone; nasal
1.5
6.9
319
2427
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.7
6.8
147
928
N07CA01
ATC
betahistine; oral
2.1
6.8
72
354
38798
ICD-8 Finland
Other disease of ear and mastoid process, Alii definiti
16.8
6.8
10
6
TPH04
NOMESCO Finland
Cathetrisation of vein
1.6
6.7
171
1131
D07AC01
ATC
betamethasone; topical
1.5
6.7
268
1977
WX110
NOMESCO Finland
Local anesthesy
1.4
6.6
522
4412
RK520
NOMESCO Finland
NA
8.8
6.6
13
15
H29
ICPC
Ear symptom/complaint other
2.0
6.5
88
474
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.7
6.5
145
923
J01FA09
ATC
clarithromycin; systemic
1.5
6.5
230
1650
38799
ICD-8 Finland
Other disease of ear and mastoid process, Other
70.3
6.4
7
*
AA1AD
NOMESCO Finland
CT of head and brain
1.5
6.4
209
1473
A02BC01
ATC
omeprazole; systemic
1.5
6.3
236
1707
DE2BG
NOMESCO Finland
Acoustic channel MRI examination with high intensity magnet
5.6
6.3
17
31
J47
ICD-10 Finland
Bronchiectasis
4.0
6.3
23
58
H02AB07
ATC
prednisone; oral
1.7
6.3
123
751
ZXA05
NOMESCO Finland
Left side
1.5
6.3
212
1498
4730A
ICD-9 Finland
Chronic sinusitis, Maxillary
4.4
6.3
21
49
H60.2
ICD-10 Finland
Malignant otitis externa
+∞
6.3
6
*
4148
FHL
Radical cutting and cavity filling
+∞
6.3
6
*
38400
ICD-8 Finland
Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) acuta
+∞
6.3
6
*
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.2
6.2
61
291
EMB30
NOMESCO Finland
Adenotomy
10.1
6.0
11
11
R03AC02
ATC
salbutamol; inhalant
1.4
6.0
396
3212
S02AA03
ATC
boric acid; otic
6.1
6.0
15
25
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007853) Bacteria identified in Skin by Aerobe culture
245
903
3.29
51.65
2.9
1.7
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
170
911
2.05
14.73
1.8
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
197
1181
1.84
12.07
2.1
2.0
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
170
980
1.89
11.76
4.8
4.6
%
31.6
32.1
0.21
125
641
(42870588) Differential panel, method unspecified - Blood
354
2567
1.60
10.52
6.5
5.5
—
—
—
0
0
(3019225) pH of Specimen
140
791
1.90
10.23
3.1
4.2
—
—
—
0
0
(3009343) pH of Capillary blood
104
537
2.05
9.84
3.2
3.8
ph
7.4
7.4
0.40
12
62
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
104
545
2.02
9.44
3.2
3.7
kpa
5.2
5.2
0.08
97
504
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
99
510
2.05
9.42
3.2
3.8
mmol/l
1.3
1.8
0.64
79
384
(3002030) Lymphocytes/100 leukocytes in Blood
454
3653
1.46
7.54
7.1
5.8
%
26.2
26.8
0.60
422
3389
(3022313) Gas panel - Capillary blood
77
394
2.04
7.47
3.2
3.9
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
443
3581
1.44
7.01
7.4
5.9
%
8.8
8.8
0.00
416
3347
(3022096) Basophils/100 leukocytes in Blood
430
3463
1.43
6.91
7.1
5.7
%
0.7
0.7
0.76
402
3227
(3006504) Eosinophils/100 leukocytes in Blood
439
3561
1.43
6.72
7.1
5.6
%
3.0
2.9
0.60
413
3315
(3018010) Neutrophils/100 leukocytes in Blood
442
3591
1.42
6.70
6.9
5.6
%
58.2
58.0
0.16
417
3357
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
63
316
2.06
6.48
1.8
1.6
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
420
3419
1.40
6.13
10.3
10.5
inr
1.3
1.3
0.05
115
976
(3013707) Erythrocyte sedimentation rate by Westergren method
643
5647
1.41
5.89
4.8
4.1
mm/h
14.3
13.2
0.99
601
5171
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
315
2456
1.42
5.82
2.7
2.6
u/l
50.4
56.7
4.17
293
2280
(3013512) EKG study
310
2416
1.42
5.72
4.8
4.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
562
4838
1.38
5.71
3.4
3.2
u/l
58.1
51.6
0.60
520
4477
(40768804) Tissue Pathology biopsy report
369
2983
1.38
5.43
2.4
2.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
84
493
1.77
5.42
3.9
3.0
e9/l
4.2
4.3
0.12
55
367
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
437
3645
1.36
5.24
5.9
6.1
mmol/l
1.2
1.2
2.31
388
3274
(3023368) Bacteria identified in Blood by Culture
299
2359
1.39
5.02
4.5
4.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
193
1410
1.46
4.98
2.0
1.8
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
151
1055
1.51
4.86
1.4
1.2
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
537
4659
1.34
4.81
5.3
5.0
mmol/l
7.0
6.8
1.43
510
4377
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
62
345
1.85
4.78
1.9
1.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
388
3213
1.35
4.74
4.4
3.9
ng/l
38.5
54.7
0.76
293
2369
(3028192) IgG subclass 2 [Mass/volume] in Serum
19
63
3.06
4.69
1.9
1.3
g/l
2.9
2.7
0.18
12
47
(3024139) IgG subclass 3 [Mass/volume] in Serum
19
63
3.06
4.69
1.9
1.3
g/l
0.4
0.4
0.02
12
47
(3027135) IgG subclass 1 [Mass/volume] in Serum
19
63
3.06
4.69
1.9
1.3
g/l
7.0
7.7
0.29
12
47
(3024980) IgG subclass 4 [Mass/volume] in Serum
27
109
2.52
4.66
2.1
1.6
g/l
0.7
0.8
0.12
17
87
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
321
2589
1.36
4.63
3.3
3.1
ng/l
1927.3
1623.9
0.60
277
2229
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
629
5604
1.35
4.63
4.2
3.8
pmol/l
15.1
14.9
0.57
556
5025
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
270
2125
1.38
4.53
2.4
2.1
mg/l
3.0
3.1
0.09
224
1789
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
113
752
1.57
4.53
3.6
3.0
ng/l
205.1
227.6
0.25
102
689
(4062490)
19
65
2.96
4.46
1.9
1.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
466
3992
1.32
4.41
5.9
6.8
mmol/l
1.2
1.2
1.66
379
3356
(3019198) Lymphocytes [#/volume] in Blood
451
3856
1.32
4.29
6.6
5.6
e9/l
1.8
1.9
1.27
406
3382
(3006315) Basophils [#/volume] in Blood
442
3789
1.31
4.05
6.7
5.5
e9/l
0.0
0.0
1.52
388
3263
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
660
5976
1.33
4.03
8.2
7.6
u/l
79.9
79.6
0.06
613
5593
(3051611) Lipemic interference index of Serum or Plasma
20
75
2.70
4.01
3.7
3.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
597
5339
1.31
3.94
5.3
4.5
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
299
2435
1.33
3.94
2.3
2.2
u/l
167.6
246.9
1.41
284
2292
(3001604) Monocytes [#/volume] in Blood
439
3773
1.30
3.89
6.6
5.5
e9/l
0.6
0.6
1.00
384
3241
(3013115) Eosinophils [#/volume] in Blood
453
3914
1.30
3.84
6.8
5.8
e9/l
0.2
0.2
1.11
402
3423
(3019309) Folate [Moles/volume] in Red Blood Cells
214
1667
1.36
3.76
1.8
1.8
nmol/l
1101.0
1193.6
0.66
152
1237
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
239
1897
1.34
3.72
2.9
2.4
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
574
5141
1.29
3.57
5.4
4.8
e6/l
5.9
3244.9
—
7
91
(3044640) Blood type and Crossmatch panel - Blood
303
2505
1.30
3.52
2.9
2.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
394
3373
1.28
3.49
2.2
2.1
pmol/l
96.7
93.9
0.44
200
1758
(3003181) Sodium [Moles/volume] in Urine
31
153
2.06
3.44
1.4
1.3
mmol/l
72.3
64.3
0.48
21
129
(3012516) Albumin [Mass/volume] in Urine
292
2413
1.30
3.38
3.4
3.3
mg/l
297.6
321.4
0.03
185
1563
(4015189)
10
27
3.73
3.36
2.7
2.3
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
16
59
2.74
3.33
1.1
1.9
e9/l
1.1
1.0
—
8
31
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
753
7025
1.32
3.24
6.8
6.2
mmol/mol
41.6
40.5
2.43
676
6461
(3024561) Albumin [Mass/volume] in Serum or Plasma
406
3520
1.26
3.16
4.3
4.8
g/l
34.2
35.0
2.04
377
3253
(3007164) IgA [Mass/volume] in Serum or Plasma
176
1365
1.35
3.16
1.6
1.4
g/l
2.6
2.6
0.11
101
828
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
70
458
1.57
3.07
6.8
10.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
565
6176
0.80
3.02
24.6
20.7
g/l
331.6
332.1
0.61
560
6132
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
734
6846
1.30
3.02
5.1
4.7
mu/l
2.0
2.0
0.02
657
6165
(3052851) Hemolysis interference index of Serum or Plasma
40
227
1.79
2.99
4.4
3.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
300
2522
1.27
2.98
3.8
3.2
mmol/l
7.1
7.5
0.95
228
2087
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
50
303
1.69
2.98
2.8
2.9
—
—
—
0
0
(4035726)
95
669
1.47
2.97
1.3
1.4
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
106
767
1.43
2.88
1.9
2.2
g/l
0.2
0.2
0.04
94
706
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
466
4139
1.24
2.84
5.9
6.3
umol/l
10.6
12.0
3.02
451
3927
(3012095) Magnesium [Moles/volume] in Serum or Plasma
165
1289
1.34
2.82
2.8
3.3
mmol/l
0.8
0.8
1.07
156
1206
(3020682) Albumin/Creatinine [Ratio] in Urine
303
2566
1.26
2.81
4.3
4.0
mg/mmol
8.3
8.7
0.05
175
1649
(3030905) Polymorphonuclear cells [#/volume] in Blood
27
139
1.97
2.72
3.1
2.9
e9/l
4.3
4.4
0.03
27
139
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
41
242
1.72
2.71
1.9
1.6
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
53
336
1.61
2.68
2.0
2.0
u/l
36.7
38.7
0.32
44
294
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
204
1654
1.30
2.67
1.6
1.7
mg/l
1.3
1.4
0.07
151
1277
(3003458) Phosphate [Moles/volume] in Serum or Plasma
141
1086
1.35
2.65
4.3
5.6
mmol/l
1.0
1.0
0.01
124
996
(3022948) Iron [Moles/volume] in Serum or Plasma
164
1292
1.32
2.65
3.0
2.5
umol/l
12.1
12.7
0.52
154
1193
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
51
322
1.62
2.63
4.3
3.1
u/ml
81.3
59.1
0.20
51
308
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
200
1623
1.29
2.60
4.9
3.9
ng/l
161.7
275.2
0.96
164
1323
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
5
7
7.17
2.55
1.0
1.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
408
3605
1.23
2.52
4.8
4.1
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
82
582
1.45
2.49
3.0
2.5
g/l
10.6
10.8
0.31
77
530
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
28
152
1.87
2.44
1.2
1.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
27
145
1.89
2.43
3.8
3.2
%
59.6
58.8
0.09
27
145
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
117
888
1.36
2.43
2.6
2.9
umol/l
8.2
9.5
0.38
102
786
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
794
7545
1.29
2.42
19.7
15.7
mg/l
25.3
26.1
0.25
679
6068
(3033658) Prothrombin time (PT) actual/Normal
236
1977
1.26
2.36
4.1
4.1
%
87.8
86.8
0.22
226
1925
(1616796) Gas panel - Central venous blood
29
163
1.80
2.29
3.8
3.9
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
12
47
2.57
2.27
2.8
2.5
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
370
3264
1.22
2.27
3.2
2.8
ug/l
139.6
142.4
0.08
324
2963
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
38
232
1.66
2.26
1.3
1.6
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
35
210
1.69
2.22
1.5
2.5
g/l
3.6
3.6
0.03
30
201
(3026782) Osmolality of Urine
200
1657
1.26
2.19
3.1
2.9
mosm/kgh2o
523.6
558.4
1.51
168
1413
(3006184) Hemoglobin [Mass/volume] in Capillary blood
30
173
1.76
2.19
2.0
2.2
g/l
119.4
126.8
1.16
21
125
(3013650) Neutrophils [#/volume] in Blood by Automated count
484
4393
1.20
2.18
8.9
8.9
e9/l
4.3
4.2
0.26
427
3840
(3035637) Corticotropin [Mass/volume] in Plasma
18
87
2.09
2.18
2.4
1.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
31
182
1.73
2.13
1.6
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
31
182
1.73
2.13
1.6
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
51
340
1.53
2.13
1.4
1.2
—
—
—
0
0
(3012501) Base excess in Blood by calculation
30
175
1.74
2.11
4.5
4.5
mmol/l
2.4
2.6
0.21
24
114
(3028026) IgM [Mass/volume] in Serum or Plasma
65
457
1.45
2.11
2.3
1.8
g/l
0.9
1.5
2.60
60
420
(3020779) Urea [Moles/volume] in Serum or Plasma
99
750
1.36
2.10
6.3
7.3
mmol/l
10.9
10.5
0.18
94
715
(3004789) Transferrin [Mass/volume] in Serum or Plasma
148
1188
1.29
2.09
3.1
2.5
g/l
2.3
2.3
0.12
140
1106
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
8
26
3.09
2.01
1.5
1.4
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
35
217
1.64
1.99
1.5
1.6
iu/ml
0.0
27.4
—
8
44
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
5
11
4.56
1.94
1.0
1.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
744
7070
1.23
1.94
4.4
4.1
mmol/l
1.4
1.3
1.89
655
6373
(3002619) Bacteria identified in Specimen by Culture
6
16
3.77
1.93
1.0
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
11
45
2.46
1.93
1.2
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
11
45
2.46
1.93
1.2
1.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
73
534
1.40
1.93
1.8
1.6
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
141
1727
0.79
1.92
3.6
3.9
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
14
65
2.17
1.88
1.1
1.1
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
6
17
3.54
1.84
1.3
2.1
nmol/l
137.8
130.2
—
6
17
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
10
40
2.52
1.84
1.2
2.4
—
—
—
0
0
(4146454)
18
94
1.93
1.81
2.1
2.8
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
57
405
1.43
1.78
2.8
2.5
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
138
1122
1.27
1.78
3.2
2.5
%
20.1
22.6
1.22
119
962
(3037522) Nuclear Ab [Titer] in Serum
120
959
1.29
1.78
1.3
1.3
titre
595.0
406.4
0.38
24
206
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
19
102
1.88
1.77
2.6
2.6
mg/l
16.6
23.4
—
7
27
(3036481) Cortisol [Moles/volume] in Serum or Plasma
89
684
1.33
1.75
2.7
2.1
nmol/l
409.9
377.8
0.49
77
624
(3026493) Urate [Moles/volume] in Serum or Plasma
236
2039
1.21
1.74
2.8
2.8
umol/l
3043.9
8010.7
1.52
202
1740
(4010399)
74
554
1.36
1.72
1.5
1.5
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
5
13
3.86
1.71
1.0
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
11
48
2.31
1.71
1.7
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
17
89
1.93
1.70
1.1
1.1
u/ml
0.2
1.3
—
8
41
(3042631) Mycobacterium sp identified in Specimen
22
126
1.76
1.69
2.4
2.6
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
138
1665
0.80
1.65
3.7
4.4
kg/l
1.0
1.0
0.52
28
221
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
209
1795
1.21
1.63
1.7
1.7
pmol/l
405.7
19204819.1
1.55
168
1458
(3002256) Pathology report gross observation
121
980
1.27
1.62
1.2
1.3
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
5
14
3.58
1.61
1.0
1.2
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
280
2475
1.18
1.60
3.3
3.3
u/l
31.4
35.5
1.43
260
2347
(40761535) Cells panel - Urine sediment
49
678
0.71
1.58
2.5
3.5
—
—
—
0
0
(3019977) pH of Arterial blood
11
50
2.21
1.57
1.5
2.7
ph
7.4
7.4
—
5
13
(3047181) Lactate [Moles/volume] in Blood
40
273
1.49
1.56
3.5
5.7
mmol/l
1.2
1.4
0.38
34
242
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
31
200
1.57
1.55
1.4
1.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
78
600
1.33
1.54
1.6
1.6
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
8
33
2.44
1.54
1.0
1.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
19
108
1.77
1.51
1.2
1.5
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
6
21
2.87
1.50
1.0
1.4
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
33
218
1.53
1.50
2.2
2.1
mg/l
11.7
12.2
0.16
27
193
(40757494) Bilirubin.total [Moles/volume] in Blood
0
45
0.00
1.50
0.0
1.6
—
45.8
—
0
5
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
44
614
0.70
1.49
3.0
2.9
ml/min/173m2
62.3
62.0
0.02
20
255
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
456
4209
1.16
1.48
2.8
2.8
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
9
37
2.45
1.48
1.0
1.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
235
2059
1.19
1.48
1.7
1.6
nmol/l
18.1
20.4
1.61
192
1730
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
342
3092
1.16
1.46
2.2
2.3
nmol/l
79.6
77.8
0.49
287
2705
(3045683) HLA typing for celiac disease panel - Blood or Tissue
7
28
2.51
1.45
1.0
1.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
19
110
1.74
1.43
1.1
1.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
25
157
1.61
1.41
3.4
2.6
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
79
618
1.30
1.41
3.9
4.1
%
0.1
0.1
0.31
23
186
(3044290) Cell count panel - Cerebral spinal fluid
22
134
1.66
1.40
1.0
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
17
96
1.78
1.39
1.6
3.9
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
120
992
1.24
1.37
2.0
1.8
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
6
23
2.62
1.37
1.0
1.0
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
83
657
1.29
1.36
3.9
4.0
%
1.0
0.9
0.23
25
204
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
760
7312
1.18
1.36
4.8
4.5
mmol/l
1.4
1.4
3.19
668
6637
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
14
75
1.88
1.34
1.1
1.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
16
90
1.79
1.33
2.1
2.0
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
44
317
1.41
1.33
2.0
2.1
ug/l
248.5
540.4
0.97
44
297
(3013139) Helicobacter pylori Ag [Presence] in Stool
59
447
1.34
1.32
1.2
1.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
136
1146
1.22
1.30
32.2
27.4
inr
1.4
1.4
0.02
24
150
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
81
1008
0.79
1.29
7.1
7.7
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
5
18
2.79
1.28
1.2
1.1
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
29
195
1.50
1.25
1.3
1.2
—
19.3
—
0
8
(3028679) Herpes simplex virus Ab [Presence] in Serum
6
25
2.41
1.24
1.0
1.2
—
—
—
0
0
(3020891) Body temperature
22
337
0.64
1.23
7.7
4.5
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
10
49
2.05
1.22
2.7
2.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
19
116
1.65
1.22
1.1
1.6
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
821
7972
1.20
1.22
12.3
10.8
u/l
26.1
25.9
0.16
791
7664
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
5
19
2.64
1.21
1.0
1.8
mmol/l
1.2
1.2
—
5
19
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
8
37
2.17
1.21
3.3
4.6
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
26
172
1.53
1.21
1.3
1.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
30
205
1.48
1.21
1.4
1.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
74
589
1.28
1.19
4.2
3.9
%
0.6
0.6
0.05
20
149
(3023419) Bacteria identified in Sputum by Culture
19
117
1.64
1.18
2.3
2.7
—
—
—
0
0
(4024509)
12
64
1.89
1.18
1.8
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
127
0.47
1.17
2.2
1.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
737
7102
1.16
1.17
18.5
14.7
ml/min/173m2
77.2
77.1
0.03
648
5875
(3019550) Sodium [Moles/volume] in Serum or Plasma
808
7842
1.18
1.16
22.8
18.6
mmol/l
139.5
139.6
0.67
788
7634
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
33
0.00
1.16
0.0
6.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
275
2485
1.15
1.16
4.2
3.4
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
809
7854
1.18
1.15
22.9
18.7
mmol/l
4.0
4.0
0.10
788
7635
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
39
2.06
1.15
1.1
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
779
7542
1.17
1.14
5.3
5.1
mmol/l
2.6
2.7
0.57
681
6854
(40761536) Microorganisms panel - Urine sediment
82
665
1.25
1.14
5.4
3.9
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
17
103
1.66
1.13
1.4
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
17
103
1.66
1.13
1.4
1.3
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
14
81
1.74
1.09
1.0
1.1
u/ml
0.5
0.8
—
5
35
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
21
136
1.56
1.09
3.9
2.7
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
29
202
1.45
1.08
1.7
1.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
105
881
1.22
1.08
4.4
3.6
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
762
7375
1.16
1.07
4.9
4.6
mmol/l
4.4
4.5
1.50
681
6740
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
118
1002
1.20
1.07
7.1
7.4
kpa
5.2
5.1
0.28
111
963
(3027801) Oxygen [Partial pressure] in Arterial blood
118
1003
1.20
1.06
7.1
7.4
kpa
11.9
11.9
0.02
111
966
(3002385) Erythrocyte distribution width [Ratio]
588
6152
0.89
1.04
23.7
19.2
%
13.9
13.8
0.80
575
6026
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
22
2.28
1.03
1.2
1.8
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
14
83
1.70
1.01
1.6
3.3
%
66.1
55.8
—
9
60
(3004616) Nuclear Ab [Presence] in Serum
15
91
1.66
1.01
1.5
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
40
300
1.35
1.00
1.8
2.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
65
522
1.26
1.00
1.2
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
757
7335
1.15
1.00
5.2
4.8
mmol/l
6.1
6.0
1.10
674
6608
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
19
123
1.56
1.00
1.2
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
33
240
1.39
0.99
1.2
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
9
49
1.84
0.98
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
9
49
1.84
0.98
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
9
49
1.84
0.98
1.1
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
11
61
1.81
0.98
1.1
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
173
1531
1.16
0.98
1.3
1.2
u/ml
4.1
1.6
0.48
36
410
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
39
293
1.34
0.97
2.2
2.5
u/ml
0.3
0.4
1.38
22
168
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
7
36
1.95
0.97
1.0
1.0
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
9
50
1.81
0.96
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
9
50
1.81
0.96
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
9
50
1.81
0.96
1.1
1.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
117
1004
1.19
0.96
7.2
7.5
mmol/l
1.5
1.2
0.37
95
779
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
32
0.00
0.95
0.0
1.3
—
6.6
—
0
32
(40761511) CBC panel - Blood by Automated count
804
7832
1.16
0.94
18.1
14.9
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
11
62
1.78
0.94
1.6
1.3
u/l
16.7
13.3
0.64
11
56
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
16
101
1.59
0.94
1.4
1.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
330
3056
1.12
0.93
5.0
5.2
ug/l
2.2
3.3
1.86
276
2713
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
50
394
1.28
0.91
3.4
3.1
pmol/l
4.5
4.5
0.12
40
339
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
21
143
1.48
0.90
1.2
1.5
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
194
1744
1.14
0.88
3.0
2.6
e6/l
6.4
4.9
0.61
165
1538
(1761482) Bacteria [#/volume] in Urine by Culture
16
241
0.66
0.88
5.3
4.8
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
70
577
1.23
0.88
4.3
4.1
%
0.0
0.1
0.19
21
154
(3051593) INR in Capillary blood by Coagulation assay
8
44
1.82
0.86
1.3
13.2
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
84
708
1.20
0.86
2.0
2.8
g/l
66.8
66.1
0.33
78
640
(3005988) Vibrio sp identified in Specimen by Organism specific culture
16
104
1.55
0.85
1.4
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
42
327
1.30
0.85
1.1
1.0
—
—
—
0
0
(1002224) Polysomnography panel
35
266
1.33
0.83
1.1
1.1
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
144
1275
1.15
0.82
2.0
2.0
s
29.8
29.9
0.10
136
1231
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
6
32
1.88
0.82
1.3
1.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
12
73
1.65
0.82
1.5
1.4
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
24
172
1.41
0.81
2.8
2.4
%
15.1
15.6
0.34
15
83
(3044889) 12 lead EKG panel
524
5475
0.91
0.81
4.5
4.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
25
181
1.39
0.80
1.2
1.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
25
0.00
0.79
0.0
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
8
48
1.67
0.79
1.3
1.3
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
26
0.00
0.78
0.0
2.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
14
90
1.56
0.78
1.0
1.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
87
745
1.18
0.76
3.0
2.6
e9/l
68.0
68.8
0.07
61
586
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
34
1.77
0.76
1.0
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
6
34
1.77
0.76
1.0
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
57
469
1.23
0.75
1.2
1.4
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
14
91
1.55
0.75
1.0
1.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
13
83
1.57
0.75
1.0
1.1
u/ml
1.9
7.2
—
6
45
(3010144) Erythrocytes [#/volume] in Synovial fluid
12
75
1.61
0.75
1.7
1.3
e6/l
7591.5
147058.9
—
6
51
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
9
54
1.67
0.74
1.1
1.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
9
54
1.67
0.74
3.0
2.4
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
7
38
1.85
0.73
1.0
1.6
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
7
38
1.85
0.73
1.0
1.6
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
5
25
2.01
0.72
5.2
1.9
nmol/l
2.4
8.9
—
5
20
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
7
39
1.80
0.72
1.0
1.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
113
995
1.15
0.71
2.0
1.8
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
5
26
1.93
0.70
1.0
1.1
iu/ml
105.3
136.5
—
5
26
(3000492) Spirometry study
79
677
1.18
0.70
1.6
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
95
827
1.16
0.70
1.4
1.6
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
9
145
0.62
0.69
1.2
1.4
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
13
85
1.54
0.69
1.2
1.2
—
66.4
—
0
6
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
10
61
1.65
0.68
1.1
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
9
59
1.53
0.68
1.1
1.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
273
2921
0.91
0.67
4.1
4.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
39
313
1.26
0.66
2.5
2.9
g/l
0.3
0.3
0.11
11
123
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
28
215
1.31
0.65
1.4
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
15
103
1.46
0.65
1.4
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
15
103
1.46
0.65
1.4
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
690
6712
1.10
0.65
20.8
17.0
%
39.0
39.4
0.43
428
4513
(3001019) Free T4 and TSH panel - Serum or Plasma
21
281
0.74
0.64
2.2
1.7
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
17
235
0.72
0.64
1.3
1.2
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
105
931
1.14
0.62
3.0
4.1
u/l
236.0
254.4
0.91
100
884
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
8
49
1.64
0.62
1.0
1.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
8
49
1.64
0.62
1.0
1.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
8
49
1.64
0.62
1.0
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
8
49
1.64
0.62
1.0
1.5
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
39
316
1.24
0.62
1.2
1.1
—
86.4
—
0
8
(1761868) Lipid panel - Serum or Plasma
230
2470
0.91
0.61
2.9
3.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
13
88
1.48
0.60
1.3
1.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
30
236
1.28
0.60
1.8
1.8
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
17
232
0.73
0.60
1.3
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
176
1913
0.90
0.59
1.3
1.3
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
8
52
1.54
0.59
1.5
1.9
nmol/l
16.4
19.5
—
8
45
(3004809) Band form neutrophils/100 leukocytes in Blood
18
131
1.38
0.59
2.3
3.5
%
2.3
1.5
0.19
13
107
(3004716) Salmonella sp identified in Stool by Organism specific culture
26
332
0.78
0.59
1.3
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
17
231
0.73
0.59
1.3
1.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
25
193
1.30
0.58
1.5
1.5
e6/l
42852.4
15012.8
0.35
18
139
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
6
36
1.67
0.56
1.0
1.0
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
90
0.55
0.56
1.0
1.0
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
10
65
1.54
0.55
1.1
1.6
—
23.0
—
0
14
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
6
37
1.63
0.55
3.5
2.4
u/ml
419.7
917.2
—
6
37
(3041096) Erythrocytes [Presence] in Urine by Automated
220
2051
1.09
0.55
3.9
3.6
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
17
125
1.37
0.54
1.3
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
214
1995
1.09
0.53
1.7
1.6
mmol/l
1.4
1.4
0.87
174
1645
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
17
226
0.75
0.52
1.4
1.7
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
16
117
1.37
0.52
1.4
1.3
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
16
117
1.37
0.52
3.5
2.0
pg
32.3
32.4
0.04
16
117
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
12
83
1.45
0.52
1.3
1.6
—
—
—
0
0
(3000991) Gas panel - Venous blood
79
698
1.14
0.51
8.9
8.8
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
43
361
1.20
0.51
1.8
1.8
ug/l
1.0
2.3
0.71
37
319
(3024731) MCV [Entitic volume]
843
8309
1.11
0.51
28.2
22.9
fl
91.3
91.4
0.04
830
8164
(4034850)
19
247
0.76
0.51
8.7
9.8
—
—
—
0
0
(3035941) MCH [Entitic mass]
843
8310
1.11
0.50
28.1
22.9
pg
30.4
30.4
0.08
830
8162
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
16
118
1.36
0.50
1.4
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
189
1758
1.09
0.50
3.2
3.2
ug/l
0.9
0.8
0.48
120
1188
(3009261) Glucose [Presence] in Urine by Test strip
361
3775
0.93
0.50
4.1
3.9
estimate
0.0
0.0
0.50
80
695
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
41
1.47
0.50
1.0
1.2
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
6
41
1.47
0.50
1.0
1.2
u/l
112.7
74.6
—
6
36
(3026361) Erythrocytes [#/volume] in Blood
843
8311
1.11
0.50
28.2
23.0
e12/l
4.4
4.5
1.99
824
8067
(3000963) Hemoglobin [Mass/volume] in Blood
843
8313
1.11
0.49
28.4
23.1
g/l
132.9
134.5
2.30
830
8164
(3010813) Leukocytes [#/volume] in Blood
843
8313
1.11
0.49
28.3
23.0
e9/l
6.9
6.8
0.72
820
8067
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
22
172
1.29
0.48
1.4
1.3
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
7
46
1.53
0.48
1.3
1.6
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
26
208
1.26
0.48
1.3
1.2
titre
—
555.0
—
0
6
(3018418) pH of Serum or Plasma
253
2389
1.08
0.47
4.3
4.0
ph
7.4
7.4
2.49
54
449
(3051651) Icteric interference index of Serum or Plasma
7
48
1.46
0.47
5.3
3.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
357
3725
0.93
0.46
5.4
5.3
estimate
0.0
0.0
0.00
84
716
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
70
619
1.14
0.46
3.3
3.8
ng/l
88.6
89.0
0.02
54
540
(3022621) pH of Urine by Test strip
56
487
1.16
0.46
4.5
3.4
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
7
49
1.43
0.46
1.0
1.2
nmol/l
136.1
151.0
—
7
49
(3017569) Oxygen content in Arterial blood
7
50
1.40
0.45
1.4
1.7
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
7
51
1.38
0.44
1.4
1.6
—
—
—
0
0
(3000012) Reticulocyte production index
7
51
1.38
0.44
1.4
1.8
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
194
2066
0.92
0.44
4.3
4.2
estimate
0.0
0.0
0.50
83
687
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
22
175
1.26
0.43
1.2
1.3
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
5
31
1.62
0.43
1.8
1.4
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
5
31
1.62
0.43
4.2
3.1
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
5
31
1.62
0.43
1.2
1.1
%
16.0
26.1
—
5
25
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
8
57
1.41
0.42
1.0
1.0
—
0.9
—
0
14
(3021788) Differential panel - Synovial fluid
19
149
1.28
0.42
1.4
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
13
96
1.36
0.41
1.0
1.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
16
0.00
0.41
0.0
7.3
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
841
8307
1.09
0.41
28.3
23.0
e9/l
245.9
243.3
0.53
823
8087
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
8
59
1.36
0.41
1.0
1.5
—
227.8
—
0
9
(3025130) Human papilloma virus identified in Specimen
8
59
1.36
0.41
1.4
1.8
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
59
1.36
0.41
1.0
1.2
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
8
61
1.31
0.39
1.5
1.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
48
548
0.87
0.39
1.4
1.4
—
—
—
0
0
(4211845)
5
35
1.43
0.39
4.2
2.8
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
5
35
1.43
0.39
1.2
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
66
591
1.13
0.38
1.7
2.6
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
10
136
0.73
0.38
1.2
1.2
u/l
32.2
37.4
—
10
118
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
37
1.35
0.37
1.0
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
9
70
1.29
0.36
1.0
1.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
287
2749
1.06
0.36
3.1
3.4
mmol/l
2.3
2.3
0.10
240
2377
(3036489) Thrombin time
31
263
1.18
0.36
1.7
2.0
s
21.3
22.2
0.44
26
238
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
9
71
1.27
0.36
1.2
1.2
u/l
13.8
13.5
—
9
62
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
34
291
1.17
0.36
1.9
2.8
g/l
0.3
1.6
2.99
28
248
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
147
1568
0.93
0.36
2.8
3.1
mmol/l
2.5
2.5
0.31
127
1379
(3024263) Appearance of Synovial fluid
6
42
1.43
0.35
1.0
1.6
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
43
1.40
0.35
1.0
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
16
200
0.80
0.34
1.1
1.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
45
1.34
0.33
1.0
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
6
45
1.34
0.33
1.3
1.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
45
1.34
0.33
1.0
1.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
25
210
1.20
0.33
4.7
4.4
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
55
611
0.89
0.32
2.2
2.2
nmol/l
12.0
13.0
0.34
46
539
(3017143) Hepatitis C virus Ab [Presence] in Serum
79
725
1.10
0.31
1.4
1.6
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
108
1007
1.08
0.30
2.3
2.5
%
1.8
1.8
0.21
88
897
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
7
54
1.30
0.30
1.0
1.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
16
129
1.24
0.30
1.6
1.6
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
33
287
1.16
0.30
3.8
3.9
mg/l
42.3
76.7
0.86
27
232
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
10
75
1.34
0.30
3.1
2.5
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
7
56
1.25
0.29
1.0
1.4
—
51.3
—
0
8
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
44
492
0.89
0.29
2.3
1.9
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
17
139
1.23
0.29
8.9
2.0
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
80
738
1.09
0.29
3.0
2.5
u/l
30.2
33.7
0.67
65
619
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
127
1197
1.07
0.28
1.4
1.3
iu/ml
16.2
35.1
5.79
34
376
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
9
118
0.76
0.27
2.3
2.5
—
878.4
—
0
8
(36304419) Bacteria [Presence] in Urine
226
2170
1.05
0.27
3.9
3.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
85
789
1.08
0.27
1.8
2.2
ug/g
221.8
146.5
0.42
63
625
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
8
65
1.23
0.27
1.3
1.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
363
3733
0.96
0.27
3.8
3.8
estimate
0.0
0.0
0.00
85
717
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
112
1052
1.07
0.27
1.7
1.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
8
66
1.21
0.26
1.0
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
131
1384
0.94
0.26
3.5
2.9
e6/l
1.6
1.2
0.46
70
828
(4306422)
12
95
1.27
0.26
1.2
1.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
11
86
1.28
0.26
13.1
2.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
5
74
0.67
0.26
1.4
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
18
151
1.20
0.25
1.3
1.7
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
9
75
1.20
0.25
1.4
1.6
—
—
—
0
0
(4281824)
9
75
1.20
0.25
1.0
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
26
227
1.15
0.24
1.4
1.4
ug/g
369.2
283.3
—
9
135
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
82
766
1.08
0.23
2.0
2.6
ug/l
4.6
6.4
1.02
70
677
(3022145) Colonoscopy Study observation
90
844
1.07
0.23
1.3
1.3
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
17
143
1.19
0.23
1.2
1.2
—
29.1
—
0
12
(3014051) Protein [Presence] in Urine by Test strip
19
162
1.18
0.23
2.4
2.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
7
92
0.76
0.22
1.1
1.3
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
40
1.25
0.22
1.0
1.1
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
34.7
—
0
6
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.0
—
257.6
—
0
5
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.1
—
333.2
—
0
5
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
16
188
0.85
0.21
1.6
2.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
91
858
1.07
0.21
3.1
4.2
ug/l
13.8
26.6
0.50
70
721
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
13
0.00
0.21
0.0
8.2
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
13
0.00
0.21
0.0
2.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
120
1143
1.06
0.20
1.4
1.3
u/ml
8.3
8.9
0.05
34
412
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
14
0.00
0.20
0.0
2.6
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
6
48
1.25
0.20
1.2
1.2
—
13.6
—
0
13
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
16
136
1.18
0.20
1.1
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
9
111
0.81
0.20
1.1
1.0
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
32
288
1.11
0.20
3.8
4.0
mg/l
47.7
50.0
0.04
26
234
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
6
49
1.23
0.20
2.7
1.5
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
15
127
1.18
0.19
3.9
2.4
u/l
3063.3
3128.1
—
6
46
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
6
51
1.18
0.19
1.2
1.6
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
6
51
1.18
0.19
1.0
1.6
g/l
0.9
1.0
—
6
51
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
20
175
1.15
0.18
1.1
1.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
255
2481
1.04
0.18
3.9
3.4
e6/l
70.5
98.7
0.25
204
1947
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
48
518
0.92
0.18
1.4
1.5
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
86
815
1.06
0.18
1.6
1.8
%
1.7
1.5
1.02
75
706
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
7
59
1.19
0.18
1.1
1.1
—
3.3
—
0
13
(40768441) Liver Pathology biopsy report
7
62
1.13
0.17
1.1
1.5
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
5
66
0.76
0.17
2.2
2.1
mg/l
6.8
4.0
—
5
61
(3051387) C reactive protein [Mass/volume] in Capillary blood
21
186
1.13
0.17
4.8
3.7
mg/l
76.0
30.8
—
8
122
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
10
120
0.83
0.16
1.5
1.6
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
8
68
1.18
0.16
1.0
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
8
71
1.13
0.16
1.0
1.9
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
8
71
1.13
0.16
1.0
1.1
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
53
565
0.93
0.16
6.0
6.3
mmol/l
25.4
24.4
1.46
48
532
(3037756) Immunofixation for Serum or Plasma
17
193
0.88
0.16
1.6
1.6
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
10
119
0.84
0.15
1.0
1.2
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
9
78
1.16
0.15
1.4
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
9
78
1.16
0.15
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
9
78
1.16
0.15
1.4
1.4
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
9
78
1.16
0.15
1.0
1.1
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
9
78
1.16
0.15
1.4
1.4
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
87
830
1.05
0.15
8.3
8.1
g/l
123.8
119.9
1.01
82
801
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
9
80
1.13
0.15
1.4
1.5
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
17
192
0.88
0.15
1.1
1.2
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
19
169
1.13
0.14
1.4
1.6
iu/l
2.4
5.6
—
8
51
(3026389) Candida sp identified in Specimen by Organism specific culture
11
93
1.18
0.14
1.5
1.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
10
118
0.85
0.14
2.8
2.9
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
13
113
1.15
0.13
1.4
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
10
117
0.85
0.13
1.2
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
110
0.82
0.13
1.1
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
24
219
1.10
0.12
3.0
2.5
ug/min
111.6
80.3
0.29
17
125
(3000330) Specific gravity of Urine by Test strip
38
406
0.93
0.12
3.8
4.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
10
85
1.18
0.12
1.2
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
37
395
0.93
0.12
1.8
1.6
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
51
538
0.95
0.12
2.3
2.0
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
30
323
0.93
0.12
2.5
3.3
u/ml
28.0
11988.0
0.79
23
275
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
72
750
0.96
0.11
1.8
1.6
—
—
—
0
0
(4094501)
21
192
1.10
0.11
1.1
1.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
105
1018
1.04
0.10
1.7
1.7
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
30
280
1.07
0.10
4.0
3.9
ratio
1.7
1.8
—
7
28
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
31
331
0.93
0.10
1.2
2.5
g/l
3.8
3.8
0.07
23
235
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
31
331
0.93
0.10
1.2
2.5
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
31
331
0.93
0.10
1.2
2.5
g/l
7.7
7.4
0.29
25
245
(3008037) Lactate [Moles/volume] in Venous blood
18
197
0.91
0.10
2.9
3.3
mmol/l
1.7
1.6
0.20
18
192
(3048929) Epstein Barr virus Ab [Presence] in Serum
22
203
1.09
0.09
1.2
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
41
431
0.95
0.09
1.2
1.2
iu/ml
91.6
145.5
0.81
17
169
(3030467) Casts [#/volume] in Urine by Automated count
230
2263
1.02
0.09
3.9
3.2
e6/l
0.3
0.5
2.36
182
1741
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
33
349
0.94
0.08
1.3
1.4
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
57
1.05
0.08
1.3
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
82
845
0.97
0.08
1.3
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
54
519
1.04
0.08
1.5
1.7
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
65
0.77
0.08
1.2
1.0
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
70
677
1.04
0.08
5.0
3.7
mmol/l
1.2
1.2
0.33
58
583
(3023410) Appearance of Cerebral spinal fluid
7
64
1.09
0.08
1.0
1.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
10
88
1.14
0.08
1.3
1.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
7
66
1.06
0.08
1.4
1.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
133
1302
1.02
0.08
3.4
3.2
e6/l
1.9
2.1
0.24
71
755
(3047352) Trisomy 18 risk [Likelihood] in Fetus
7
68
1.03
0.08
1.4
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
7
68
1.03
0.08
1.4
1.4
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
6
73
0.82
0.07
1.3
1.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
193
1899
1.02
0.07
8.0
6.7
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
40
382
1.05
0.07
3.5
2.8
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
15
137
1.10
0.07
1.6
1.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
158
1609
0.98
0.07
5.0
4.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
8
78
1.03
0.07
1.0
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
8
78
1.03
0.07
1.0
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
8
78
1.03
0.07
1.0
1.5
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
7
82
0.85
0.07
1.1
2.6
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
14
153
0.91
0.07
1.4
1.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
7
84
0.83
0.07
1.1
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
13
118
1.10
0.07
17.0
3.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
9
86
1.05
0.07
1.3
1.3
nmol/l
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
18
167
1.08
0.07
8.8
2.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
8
93
0.86
0.06
1.0
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
9
105
0.86
0.06
1.3
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
21
197
1.07
0.06
1.3
1.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
242
2448
0.98
0.06
4.0
4.5
%
21.6
21.4
0.06
113
1220
(3027456) Digoxin [Moles/volume] in Serum or Plasma
23
217
1.06
0.06
3.7
3.3
nmol/l
0.7
0.8
0.61
18
175
(3027944) Amphetamines [Presence] in Urine
17
182
0.93
0.05
3.4
2.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
21
222
0.94
0.05
1.1
1.6
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
335
3376
0.99
0.05
13.0
9.6
e9/l
0.0
0.0
1.04
286
2771
(40768806) Pleura Pathology biopsy report
10
110
0.91
0.05
1.8
1.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
15
140
1.07
0.04
1.1
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
42
408
1.03
0.04
1.3
1.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
287
2851
1.01
0.03
4.4
3.8
e6/l
107.5
115.7
0.08
213
2079
(3027008) Opiates [Presence] in Urine
19
181
1.05
0.03
8.4
2.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
19
181
1.05
0.03
8.3
2.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
10
92
1.09
0.03
3.3
3.5
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
13
122
1.07
0.02
3.7
2.9
u/ml
5.5
36.7
0.49
13
117
(3015171) Extractable nuclear Ab [Units/volume] in Serum
27
261
1.04
0.02
1.3
1.2
—
1.4
—
0
22
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
16
168
0.95
0.02
1.3
1.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
13
137
0.95
0.01
1.2
1.3
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
294
2951
0.99
0.01
3.8
3.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
19
183
1.04
0.01
8.5
2.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
21
203
1.04
0.01
1.8
1.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
21
203
1.04
0.01
1.3
1.6
—
—
—
0
0
(3008898) HLA-B27 [Presence]
22
226
0.97
0.00
1.0
1.1
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
11
108
1.02
0.00
2.4
1.9
%
85.2
89.6
0.45
11
108
(40768793) Breast Pathology biopsy report
16
158
1.01
0.00
1.1
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
53
532
1.00
0.00
1.6
1.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
10
97
1.03
0.00
1.5
1.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
25
251
1.00
0.00
1.8
1.8
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
13
131
0.99
0.00
1.2
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
60
597
1.01
0.00
4.2
4.3
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
10
105
0.95
0.00
1.2
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
14
135
1.04
0.00
1.2
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
8
88
0.91
0.00
1.3
1.6
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3013762) Body weight Measured
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
31
310
1.00
0.00
1.2
2.6
g/l
2.9
3.2
1.17
23
239
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
8
84
0.95
0.00
1.1
1.1
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(4212803)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
6
60
1.00
0.00
1.0
1.0
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
24
240
1.00
0.00
2.1
1.8
mg/l
5.3
3.2
0.50
18
181
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
2.6
—
0
5
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003721) Smooth muscle Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
6
67
0.89
0.00
1.5
1.7
%
12.8
10.5
—
6
67
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
5.8
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
5
0.00
0.00
0.0
5.2
—
384.8
—
0
5
(3001729) Color of Synovial fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
7
77
0.91
0.00
1.0
1.2
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758358) Immune stain study
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
15
150
1.00
0.00
1.4
1.3
miu/ml
151.2
251.5
—
6
62
(3002032) Base excess in Venous blood by calculation
78
780
1.00
0.00
3.1
3.6
mmol/l
1.9
2.0
0.12
68
620
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
6.1
—
0
7
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3007916) DNA double strand Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
6.0
—
0.4
—
0
6
(3025315) Body weight
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
1.5
—
0
5
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
8
0.00
0.00
0.0
4.9
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
7
69
1.01
0.00
1.3
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
7
69
1.01
0.00
1.4
1.5
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint H8_MASTCHRON and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H8_MASTCHRON | 1.062 [0.92, 1.23] | 0.423 |
| Birth year | 0.993 [0.98, 1.0] | 0.116 |
During the follow-up period (1.1.1998 — 31.12.2019), 301 out of 1336 females with H8_MASTCHRON died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H8_MASTCHRON | 1.065 [0.91, 1.24] | 0.417 |
| Birth year | 0.987 [0.98, 1.0] | 0.007 |
During the follow-up period (1.1.1998 — 31.12.2019), 353 out of 1435 males with H8_MASTCHRON died.
Mortality risk
Mortality risk for people of age
years, who have H8_MASTCHRON.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.084% | 0.166% |
| 5 | 0.55% | 1.315% |
| 10 | 1.418% | 3.106% |
| 15 | 2.849% | 5.996% |
| 20 | 5.255% | 10.158% |
Relationships between endpoints
↥Index endpoint: H8_MASTCHRON – Chronic mastoiditis
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data